India to Myanmar: Flucloxacillin Export Trade Route
India has recorded 46 verified shipments of Flucloxacillin exported to Myanmar, representing a combined trade value of $632.6K USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $13.8K USD. The leading Indian exporter is SAKAR HEALTHCARE LIMITED, which accounts for 31% of total export value with 11 shipments worth $194.4K USD. On the buying side, LWIN AND MYINT TRADING CO. LTD. is the largest importer in Myanmar with $148.4K USD in purchases. The top 3 suppliers — SAKAR HEALTHCARE LIMITED, MEDOPHARM PRIVATE LIMITED , MEDOPHARM PRIVATE LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Flucloxacillin corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $632.6K USD. The route is dominated by SAKAR HEALTHCARE LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's flucloxacillin manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $13.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with flucloxacillin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 23.6%, placing it at rank #10 among India's top flucloxacillin export destinations globally.
On the import side, key buyers of Indian flucloxacillin in Myanmar include LWIN AND MYINT TRADING CO. LTD. , M/S. ROYAL DISTRIBUTION CO. LTD. , ROYAL DISTRIBUTION CO. LIMITED and 12 others. LWIN AND MYINT TRADING CO. LTD. is the single largest importer with 6 shipments valued at $148.4K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ2
- Primary modeSea freight
- Top portTUGLAKABAD ICD (INTKD6)
Market Position
- Global rank#10
- Annual growth+23.6%
- Demand growth+21.8%
- Regulatory ease82/100
Top 10 Indian Flucloxacillin Exporters to Myanmar
Showing top 10 of 11 Indian suppliers exporting Flucloxacillin to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SAKAR HEALTHCARE LIMITED Avg $17.7K per shipment | 11 | $194.4K | 30.7% |
| 2 | MEDOPHARM PRIVATE LIMITED Avg $24.7K per shipment | 6 | $148.4K | 23.5% |
| 3 | MEDOPHARM PRIVATE LIMITED Avg $33.1K per shipment | 3 | $99.3K | 15.7% |
| 4 | SAKAR HEALTHCARE LIMITED Avg $23.8K per shipment | 4 | $95.0K | 15.0% |
| 5 | THEON PHARMACEUTICALS LIMITED Avg $5.3K per shipment | 10 | $52.8K | 8.3% |
| 6 | THEON PHARMACEUTICALS LIMITED Avg $9.5K per shipment | 2 | $18.9K | 3.0% |
| 7 | DECINA PHARMA PRIVATE LIMITED Avg $2.4K per shipment | 5 | $11.8K | 1.9% |
| 8 | MEDICO REMEDIES LIMITED Avg $4.2K per shipment | 2 | $8.5K | 1.3% |
| 9 | AMN LIFE SCIENCE PRIVATE LIMITED Avg $1.7K per shipment | 1 | $1.7K | 0.3% |
| 10 | SCOTT EDIL PHARMACIA LIMITED Avg $1.6K per shipment | 1 | $1.6K | 0.3% |
This table shows the top 10 of 11 Indian companies exporting flucloxacillin to Myanmar, ranked by total trade value. The listed exporters are: SAKAR HEALTHCARE LIMITED, MEDOPHARM PRIVATE LIMITED , MEDOPHARM PRIVATE LIMITED, SAKAR HEALTHCARE LIMITED , THEON PHARMACEUTICALS LIMITED , THEON PHARMACEUTICALS LIMITED, DECINA PHARMA PRIVATE LIMITED, MEDICO REMEDIES LIMITED, AMN LIFE SCIENCE PRIVATE LIMITED, SCOTT EDIL PHARMACIA LIMITED. SAKAR HEALTHCARE LIMITED is the dominant supplier with 11 shipments worth $194.4K USD, giving it a 31% market share. The top 3 suppliers together account for 70% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to Myanmar Flucloxacillin export route.
Top 10 Flucloxacillin Importers in Myanmar
Showing top 10 of 15 known buyers in Myanmar receiving Flucloxacillin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian flucloxacillin in Myanmar include LWIN AND MYINT TRADING CO. LTD. , M/S. ROYAL DISTRIBUTION CO. LTD. , ROYAL DISTRIBUTION CO. LIMITED, ROYAL DISTRIBUTION CO LIMITED, ROYAL DISTRIBUTION CO. LTD., among 15 total buyers. The largest importer is LWIN AND MYINT TRADING CO. LTD. , accounting for $148.4K USD across 6 shipments — representing 23% of all flucloxacillin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LWIN AND MYINT TRADING CO. LTD. | 6 | $148.4K | 23.5% |
| 2 | M/S. ROYAL DISTRIBUTION CO. LTD. | 4 | $95.0K | 15.0% |
| 3 | ROYAL DISTRIBUTION CO. LIMITED | 1 | $59.6K | 9.4% |
| 4 | ROYAL DISTRIBUTION CO LIMITED | 1 | $59.5K | 9.4% |
| 5 | ROYAL DISTRIBUTION CO. LTD. | 6 | $56.1K | 8.9% |
| 6 | ABC INTERNATIONAL LTD. | 10 | $52.8K | 8.3% |
| 7 | Lwin And Myint Trading Company | 2 | $49.7K | 7.9% |
| 8 | MEGA LIFESCIENCES PUBLIC COMPANY | 1 | $49.6K | 7.8% |
| 9 | ROYAL DISTRIBUTION CO LTD | 3 | $19.1K | 3.0% |
| 10 | ABC INTERNATIONAL LTD. | 2 | $18.9K | 3.0% |
Showing top 10 of 15 Flucloxacillin importers in Myanmar on this route.
Top 10 Flucloxacillin Formulations Imported by Myanmar
Showing top 10 of 27 product formulations shipped on the India to Myanmar Flucloxacillin route, ranked by trade value
Myanmar imports a wide range of flucloxacillin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — AMOXICILLIN AND FLUCLOXACILLIN CAPSULES — accounts for $173.2K USD across 7 shipments. There are 27 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | AMOXICILLIN AND FLUCLOXACILLIN CAPSULES | 7 | $173.2K | 27.4% |
| 2 | AMOXICILLIN AND FLUCLOXACILLIN CAPSULE 2 | 2 | $64.0K | 10.1% |
| 3 | AMOXICILLIN AND FLUCLOXACILLIN CAPSULES(SUPRAMOX CAPSULE) | 1 | $59.6K | 9.4% |
| 4 | AMOXYCILLIN & FLUCLOXACILLIN CAPSULES SUPRAMOX DRY SYRUP AS PER DOCUMENT | 1 | $59.5K | 9.4% |
| 5 | AMOXICILLIN AND FLUCLOXACILLIN CAPSULES500MGNOS | 1 | $49.6K | 7.8% |
| 6 | AMOXICILLIN AND FLUCLOXACILLIN CAPSULES(SUPRAMOX CAPSULE)NOS | 3 | $42.0K | 6.6% |
| 7 | AMOXYCILLIN & FLUCLOXACILLIN FOR ORAL SU | 2 | $31.1K | 4.9% |
| 8 | AMOXICILLIN AND FLUCLOXACILLIN CAPSULES | 1 | $24.9K | 3.9% |
| 9 | (Flucloxacillin capsules BP 500 mg)Fluci | 2 | $20.1K | 3.2% |
| 10 | Flucloxacillin capsules BP 250 mg(Flucil | 2 | $14.8K | 2.3% |
Showing top 10 of 27 Flucloxacillin formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
TUGLAKABAD ICD (INTKD6) handles the highest volume with 12 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's flucloxacillin exports to Myanmar are driven primarily by a handful of large-scale manufacturers. SAKAR HEALTHCARE LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SAKAR HEALTHCARE LIMITED, MEDOPHARM PRIVATE LIMITED , MEDOPHARM PRIVATE LIMITED — together account for 70% of total trade value on this route. The average shipment value of $13.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as amoxicillin and flucloxacillin capsule 2 and amoxicillin and flucloxacillin capsules(supramox capsule), suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LWIN AND MYINT TRADING CO. LTD. is the largest importer with 6 shipments worth $148.4K USD — representing 23% of all flucloxacillin imports from India on this route. A total of 15 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $632.6K
- Avg. Shipment
- $13.8K
- Suppliers
- 11
- Buyers
- 15
- Transit (Sea)
- ~25 days
- Annual Growth
- +23.6%
Related Analysis
Other Flucloxacillin Routes
Unlock the Full India to Myanmar Flucloxacillin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 46 shipments on this route.
Frequently Asked Questions — India to Myanmar Flucloxacillin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Flucloxacillin to Myanmar?
The leading Indian exporters of Flucloxacillin to Myanmar are SAKAR HEALTHCARE LIMITED, MEDOPHARM PRIVATE LIMITED , MEDOPHARM PRIVATE LIMITED. SAKAR HEALTHCARE LIMITED holds the largest market share at approximately 31% of total trade value on this route.
Q What is the total value of Flucloxacillin exports from India to Myanmar?
India exports Flucloxacillin to Myanmar worth approximately $632.6K USD across 46 recorded shipments. The average value per shipment is $13.8K USD.
Q Which ports does India use to ship Flucloxacillin to Myanmar?
The most active port of origin is TUGLAKABAD ICD (INTKD6) with 12 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Myanmar for Flucloxacillin?
The average transit time for Flucloxacillin shipments from India to Myanmar is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Myanmar Flucloxacillin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.6% with demand growth tracking at 21.8%. The route is ranked #10 among India's top Flucloxacillin export destinations globally.
Q How many suppliers are active on the India to Myanmar Flucloxacillin route?
There are currently 11 active Indian suppliers exporting Flucloxacillin to Myanmar. The market is moderately concentrated with SAKAR HEALTHCARE LIMITED accounting for 31% of total shipment value.
Q Who are the main importers of Flucloxacillin from India in Myanmar?
The leading importers of Indian Flucloxacillin in Myanmar include LWIN AND MYINT TRADING CO. LTD. , M/S. ROYAL DISTRIBUTION CO. LTD. , ROYAL DISTRIBUTION CO. LIMITED, ROYAL DISTRIBUTION CO LIMITED, ROYAL DISTRIBUTION CO. LTD.. LWIN AND MYINT TRADING CO. LTD. is the largest buyer with 6 shipments worth $148.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Flucloxacillin.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 15 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 46 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
46 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists